NCT01498458 Pazopanib in Combination With Capecitabine in Patients With Metastatic Breast Cancer Status COMPLETED Phase PHASE1
NCT01482156 Dose Finding Study of RAD001 (Everolimus, Afinitor®) in Combination With BEZ235 in Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT01477060 Modulation of Response to Hormonal Therapy With Lapatinib and/or Metformin in Patients With Metastatic Breast Cancer Status TERMINATED Phase PHASE2
NCT01451580 Lipo-dox and Cyclophosphamide /5-Fluorouracil in Patients With Metastatic Breast Cancer Status UNKNOWN Phase PHASE2
NCT01439191 Study of Cipterbin®, Used Alone or With Vinorelbine in Patients With HER2/Neu-overexpressed Metastatic Breast Cancer Status COMPLETED Phase PHASE2
NCT01433614 Epirubicin and Paclitaxel, Alone or Together With Capecitabine as First Line Treatment in Metastatic Breast Cancer Status COMPLETED Phase PHASE3
NCT01423695 Weekly Paclitaxel and Trastuzumab in Metastatic Breast Cancer Status COMPLETED Phase PHASE2
NCT01421017 Toll-like Receptor (TLR) 7 Agonist, Cyclophosphamide, and Radiotherapy for Breast Cancer With Skin Metastases Status COMPLETED Phase PHASE1/PHASE2
NCT01416558 Nab-paclitaxel in Metastatic Breast Cancer Patients Failing Solvent Based Taxane (Tiffany) Status TERMINATED Phase PHASE2
NCT01414933 High Throughput Technologies to Drive Breast Cancer Patients to Specific Phase I/II Trials of Targeted Agents Status COMPLETED Phase N/A
NCT01401959 Trial of Eribulin in Patients Who Do Not Achieve Pathologic Complete Response (pCR) Following Neoadjuvant Chemotherapy Status COMPLETED Phase PHASE2
NCT01392586 Systemic Therapy With or Without Upfront Surgery in Metastatic Breast Cancer Status TERMINATED Phase PHASE3
NCT01387373 Intra-hepatic Chemotherapy in Patient With Non-resectable Liver Metastases From Breast Cancer Status COMPLETED Phase PHASE2
NCT01387295 Intra-hepatic Chemotherapy in Patients With Liver Metastases From Breast Cancer and Limited Extrahepatic Disease Status COMPLETED Phase PHASE2
NCT01380808 Capecitabine and Pseudomonas Aeruginosa Combination in Metastatic Breast Cancer (MBC) Status COMPLETED Phase PHASE2
NCT01377324 Molecular Imaging of Fulvestrant Effects on Availability of ER Binding Sites Status COMPLETED Phase PHASE2
NCT01373710 Intrathecal Trastuzumab Administration in Metastatic Breast Cancer Patients Developing Carcinomatous Meningitis Status COMPLETED Phase PHASE1/PHASE2